Bioanalytical method for quantification of Solifenacin in rat plasma by LC-MS/MS and its application to pharmacokinetic study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2093-3371
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bioanalytical method for quantification of Solifenacin in rat plasma by LC-MS/MS and its application to pharmacokinetic study ; volume:5 ; number:1 ; day:18 ; month:7 ; year:2014 ; pages:1-8 ; date:12.2014
Journal of analytical science and technology ; 5, Heft 1 (18.7.2014), 1-8, 12.2014
- Urheber
-
Puttagunta, Srinivasa Babu
Shaik, Rihana Parveen
Bannoth, Chandrasekhar Kothapalli
Challa, Bala Sekhara Reddy
Awen, Bahlul Zayed Sh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40543-014-0035-0
- URN
-
urn:nbn:de:101:1-2021083119384065629034
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Puttagunta, Srinivasa Babu
- Shaik, Rihana Parveen
- Bannoth, Chandrasekhar Kothapalli
- Challa, Bala Sekhara Reddy
- Awen, Bahlul Zayed Sh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drosophila ecdysteroidome by LC-MS/MS
Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Development and validation of bexarote by bioanalytical methods using liquid chromatography-tandem mass spectroscopy (LC-MS/MS)
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC–MS/MS determination and pharmacokinetic study of columbianadin in rat plasma after intravenous administration of pure columbianadin
Drosophila ecdysteroidome by LC-MS/MS
Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Development and validation of bexarote by bioanalytical methods using liquid chromatography-tandem mass spectroscopy (LC-MS/MS)
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics
LC–MS/MS determination and pharmacokinetic study of columbianadin in rat plasma after intravenous administration of pure columbianadin
Drosophila ecdysteroidome by LC-MS/MS
Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Development and validation of bexarote by bioanalytical methods using liquid chromatography-tandem mass spectroscopy (LC-MS/MS)
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS
Inferring serum proteolytic activity from LC-MS/MS data
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Optimal precursor ion selection for LC-MS/MS based proteomics
Visualization of LC‐MS/MS proteomics data in MaxQuant
Optimal precursor ion selection for LC-MS/MS based proteomics
Interrogating data-independent acquisition LC–MS/MS for affinity proteomics